Contact Us
Home
About
Management Team
Board of Directors
Scientific Advisory Board
Research
The Technology
Cole Relaxation Frequency
Platform Technology
Predictive Technology
MarginScan™
nsCanary™
Targeted Drug Delivery
Electrical Mammogram
Clinical Results
Press
Contact Us
Home
About
Management Team
Board of Directors
Scientific Advisory Board
Research
The Technology
Cole Relaxation Frequency
Platform Technology
Predictive Technology
MarginScan™
nsCanary™
Targeted Drug Delivery
Electrical Mammogram
Clinical Results
Press
Contact Us
Home
About
Management Team
Board of Directors
Scientific Advisory Board
Research
The Technology
Cole Relaxation Frequency
Platform Technology
Predictive Technology
MarginScan™
nsCanary™
Targeted Drug Delivery
Electrical Mammogram
Clinical Results
Press
Contact Us
About
Search
Search
Recent Posts
NovaScan Announces the Appointment of Two Luminary Advisors
Epredia and NovaScan Announce Intent for U.S. Distribution Agreement for MarginScanTM Device for Non-Melanoma Skin Cancer Detection
NovaScan and Dr Paul Grippo Receive Competitive Award for Pancreatic Cancer Research
NovaScan Participating in Multiple Conferences in Lung and GI
NovaScan Announces Launch of its nsCanary™ Lung Trial at University of Chicago
Recent Comments
